Australia awards 1st patent for MRSA detection technology: 5 key points

Phoenix-based Translational Genomics Research Institute and Flagstaff-based Northern Arizona University received the first patent for their antibiotic-resistant staph infection detection technology, according to The Daily Courier.

Here are five key points:

1. Australia issued the patent.

2. The one-hour test is designed to accurately pinpoint Methicillin-resistant Staphylococcus aureus.

3. The technology can also detect the common antibiotic-resistant Coagulase Negative Staphylococcus.

4. Other tests do not detect CNS, which is much more common than MRSA.

5. Next, the institutions hope to receive U.S. patent approval.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers

Featured Podcast